Reproductive health and family planning needs among HIV-infected women in Sub-Saharan Africa

Current HIV Research

Volumn 11, Issue 2, 2013, Pages 160-168

  Sarnquist, Clea C ^a   Rahangdale, Lisa ^b   Maldonado, Yvonne ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Family planning; HIV prevention; HIV AIDS in women; Pregnancy; Preventing mother to child HIV transmission; Reproductive health

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

AFRICA; CONDOM; COUNSELING; DISEASE COURSE; DISEASE TRANSMISSION; EDUCATION; FAMILY PLANNING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAUTERINE CONTRACEPTIVE DEVICE; PREGNANCY; PREGNANCY TERMINATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCTIVE HEALTH; REVIEW; RISK FACTOR; SAFETY; SEXUALLY TRANSMITTED DISEASE;

AFRICA SOUTH OF THE SAHARA; ANTI-HIV AGENTS; CONTRACEPTION; CONTRACEPTION BEHAVIOR; DECISION MAKING; FAMILY PLANNING SERVICES; FEMALE; FERTILITY; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MATERNAL-CHILD HEALTH CENTERS; MOTHERS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REPRODUCTIVE HEALTH SERVICES;

EID: 84875823171     PISSN: 1570162X     EISSN: 18734251     Source Type: Journal    
DOI: 10.2174/1570162X11311020008     Document Type: Review

References (120)

1. United Nations. The Millenium Development Goals Report 2008. Accessed January 15, 2011. Available from: http://mdgs.un.org/un sd/mdg/Resources/Static/Products/Progress2008/MDG_Report_20 08_En.pdf#page=31.
2. Taulo F, Berry M, Tsui A, et al. Fertility intentions of HIV-1 infected and uninfected women in Malawi: a longitudinal study. AIDS Behav 2009; 13 Suppl 1: 20-7.
3. Yeatman S. The impact of HIV status and perceived status on fertility desires in rural Malawi. AIDS Behav 2009; 13 Suppl 1: 12-9.
4. Anand A, Shiraishi R, Bunnell R, et al. Knowledge of HIV status, sexual risk behaviors and contraceptive need among people living with HIV in Kenya and Malawi. AIDS 2009; 23(12): 1565-73.
5. Cooper D, Moodley J, Zweigenthal V, Bekker L-G, Shah I, Myer L. Fertility intentions and reproductive health care needs of people living with HIV in Cape Town, South Africa: implications for integrating reproductive health and HIV care services. AIDS Behav 2009; 13 Suppl 1: 38-46.
6. Elul B, Delvaux T, Munyana E, et al. Pregnancy desires, and contraceptive knowledge and use among prevention of mother-tochild transmission clients in Rwanda. AIDS 2009; 23(1): S19-26.
7. USAID. Issue Brief: Family Plannning Improves Quality of Life and Opportunities for Women 2009.
8. Mugumya E. Small families mean better health for mothers and kids. Afr Women Health 1994; 2(3): 28-30.
9. Chilongozi D, Wang L, Brown L, et al. Morbidity and mortality among a cohort of human immunodeficiency virus type 1-infected and uninfected pregnant women and their infants from Malawi, Zambia, and Tanzania. Pediatr Infect Dis J 2008; 27(9): 808-14.
10. Habib NA, Daltveit AK, Bergsj P, Shao J, Oneko O, Lie RT. Maternal HIV status and pregnancy outcomes in northeastern Tanzania: a registry-based study. BJOG 2008; 115(5): 616-24.
11. Rollins N, Coovadia H, Bland R, et al. Pregnancy outcomes in HIV-infected and uninfected women in rural and urban South Africa. J Acquir Immune Defic Syndr 2007; 44(3): 321-8.
12. Rochat T, Richter L, Doll H, Buthelezi N, Tomkins A, Stein A. Depression among pregnant rural South African women undergoing HIV testing. JAMA 2006; 295(12): 1376-8.
13. Halperin D, Stover J, Reynolds H. Benefits and costs of expanding access to family planning programs to women living with HIV. AIDS 2009; 23(1): S123-30.
14. Hladik W, Stover J, Esiru G, Harper M, Tappero J. The contribution of family planning towards the prevention of vertical HIV transmission in Uganda. PLoS One 2009; 4(11): e7691.
15. Reynolds HW, Janowitz B, Wilcher R, Cates W. Contraception to prevent HIV-positive births: current contribution and potential cost savings in PEPFAR countries. Sex Transm Infect 2008; 84 Suppl 2: ii49-53.
16. Reynolds HW, Janowitz B, Homan R, Johnson L. The value of contraception to prevent perinatal HIV transmission. Sex Transm Dis 2006; 33(6): 350-6.
17. Best K. Family Planning and the Prevention of Mother-to-Child Transmission of HIV: A Review of the Literature 2004. Available from: http://www.fhi.org/NR/rdonlyres/ei54f7dvn6ubask46ypmuek yrpvh7it562xfp75sx5dx5r3zricxfkhqhwi3hx4gkp53b6qh3wzh2e/FP PMTCTenrh.pdf.
18. Semprini A, Fiore S. HIV and reproduction. Curr Opin Obstet Gynecol 2004; 16(3): 257-62.
19. Delvaux T, Nostlinger C. Reproductive choice for women and men living with HIV: contraception, abortion and fertility. Reprod Health Matters 2007; 15(29 Suppl): 46-66.
20. Coll O, Lopez M, Hernandez S. Fertility choices and management for HIV-positive women. Curr Opin HIV AIDS 2008; 3(2): 186-92.
21. Richey C, Setty V. Family Planning Choices for Women With HIV. Baltimore: Johns Hopkins Bloomberg School of Public Health 2007 August.
22. Heikinheimo O, Lhteenmki P. Contraception and HIV infection in women. Hum Reprod Update 2009; 15(2): 165-76.
23. Heys J, Kipp W, Jhangri G, Alibhai A, Rubaale T. Fertility desires and infection with the HIV: results from a survey in rural Uganda. AIDS 2009; 23(1): S37-45.
24. Peltzer K, Chao L-W, Dana P. Family planning among HIV positive and negative prevention of mother-to-child transmission (PMTCT) clients in a resource poor setting in South Africa. AIDS Behav 2009; 13(5): 973-9.
25. Kaida A, Andia I, Maier M, et al. The potential impact of antiretroviral therapy on fertility in Sub-Saharan Africa. Current HIV/AIDS Rep 2006; 3(4): 187-94.
26. Johnson K, Akwara P, Rutstein S, Bernstein S. Fertility preferences and the need for contraception among women living with HIV: the basis for a joint action agenda. AIDS 2009; 23(1): S7-17.
27. Beyeza-Kashesya J, Ekstrom A, Kaharuza F, Mirembe F, Neema S, Kulane A. My partner wants a child: a cross-sectional study of the determinants of the desire for children among mutually disclosed sero-discordant couples receiving care in Uganda. BMC Public Health 2010; 10: 247.
28. Mantell J, Smit J, Stein Z. The right to choose parenthood among HIV-infected women and men. J Public Health Policy 2009; 30(4): 367-78.
29. Ansell N. 'Because it's our culture!' (Re)negotiating the meaning of Lobola in Southern African secondary schools. J South Afr Stud 2001; 27(4): 697-716.
30. Piotrow PT, Kincaid DL, Hindin MJ, et al. Changing men's attitudes and behavior: the Zimbabwe Male Motivation Project. Stud Fam Plann 1992; 23(6 Pt 1): 365-75.
31. Feldman R, Manchester J, Maposhere C. Positive Women: Voice and Choices-Zimbabwe Report. Harare, Zimbabwe: International Community of Women Living with HIV/AIDS; 2002 Accessed 8 Jan 2010. Available from: http://www.icw.org/icw/files/VoicesCho ices.pdf.
32. Moon MW, Khumalo-Sakutukwa GN, Heiman JE, Mbizvo MT, Padian NS. Vaginal microbicides for HIV/STI prevention in Zimbabwe: what key informants say. J Transcult Nurs 2002; 13(1): 19-23.
33. van de Wijgert J, Khumalo-Sakatukwa, G, Coggins, C, et al. Men's attitudes toward vaginal microbicides and microbocide trials in Zimbabwe. International Family Planning Perspectives 1999; 25(1): 15-20.
34. Central Statistical Office (CSO) [Zimbabwe], Macro International Inc. Zimbabwe Demographic and Health Survey 2005-2006. Calverton, MD: CSO and Macro International Inc.2007.
35. Homsy J, Bunnell R, Moore D, et al. Reproductive Intentions and Outcomes among Women on Antiretroviral Therapy in Rural Uganda: A Prospective Cohort Study. PLoS One 2009; 4(1): e4149.
36. Desgrees-Du-Lou A, Msellati P, Viho I, et al. Contraceptive use, protected sexual intercourse and incidence of pregnancies among African HIV-infected women. DITRAME ANRS 049 Project, Abidjan 1995-2000. Int J STD AIDS 2002; 13(7): 462-8.
37. Myer L, Morroni C, Rebe K. Prevalence and determinants of fertility intentions of HIV-infected women and men receiving antiretroviral therapy in South Africa. AIDS Patient Care STDS 2007; 21(4): 278-85.
38. Maier M, Andia I, Emenyonu N, et al. Antiretroviral therapy is associated with increased fertility desire, but not pregnancy or live birth, among HIV+ women in an early HIV treatment program in rural Uganda. AIDS Behav 2009; 13 Suppl 1: 28-37.
39. Myer L, Carter R, Katyal M, Toro P, El-Sadr W, Abrams E. Impact of antiretroviral therapy on incidence of pregnancy among HIVinfected women in Sub-Saharan Africa: a cohort study. PLoS Med 2010; 7(2): e1000229.
40. Kaida A, Laher F, Strathdee S, et al. Contraceptive Use and Method Preference among Women in Soweto, South Africa: The Influence of Expanding Access to HIV Care and Treatment Services. PLoS One 2010; 5(11): e13868.
41. Curtis K, Nanda K, Kapp N. Safety of hormonal and intrauterine methods of contraception for women with HIV/AIDS: a systematic review. AIDS 2009; 23 Suppl 1: S55-67.
42. Vogler M, Patterson K, Kamemoto L, et al. Contraceptive Efficacy of Oral and Transdermal Hormones When Co-Administered With Protease Inhibitors in HIV-1-Infected Women: Pharmacokinetic Results of ACTG Trial A5188. J Acquir Immune Defic Syndr 2010; 55(4): 473-82.
43. Stringer E, Giganti M, Carter R, El-Sadr W, Abrams E, Stringer J. Hormonal contraception and HIV disease progression: a multicountry cohort analysis of the MTCT-Plus Initiative. AIDS 2009; 23 Suppl 1: S69-77.
44. Stuart G. Fourteen million women with limited options: HIV/AIDS and highly effective reversible contraception in Sub-Saharan Africa. Contraception 2009; 80(5): 412-6.
45. Mitchell HS, Stephens E. Contraception choice for HIV positive women. Sex Transm Infect 2004; 80(3): 167-73.
46. Allen S. Why is fertility an issue for HIV-infected and at-risk women? J Acquir Immune Defic Syndr 2005; 38 Suppl 1: S1-3.
47. Stringer E, Kaseba C, Levy J, et al. A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol 2007; 197(2): 144. e1-8.
48. Polis C, Wawer M, Kiwanuka N, et al. Effect of hormonal contraceptive use on HIV progression in female HIV seroconverters in Rakai, Uganda. AIDS 2010; 24(12): 1937-44.
49. Richardson B, Otieno P, Mbori-Ngacha D, Overbaugh J, Farquhar C, John-Stewart G. Hormonal contraception and HIV-1 disease progression among postpartum Kenyan women. AIDS 2007; 21(6): 749-53.
50. Heffron R, Donnell D, Rees H, et al. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 2012; 12(1): 19-26.
51. Morrison C, Skoler Karpoff S, Kwok C, et al. Hormonal Contraception and the Risk of HIV Acquisition among Women in South Africa. AIDS 2012; 26(4): 497-504.
52. Stringer E, Antonsen E. Hormonal contraception and HIV disease progression. Clin Infect Dis 2008; 47(7): 945-51.
53. Baeten J, Lavreys L, Overbaugh J. The influence of hormonal contraceptive use on HIV-1 transmission and disease progression. Clin Infect Dis 2007; 45(3): 360-9.
54. Mildvan D, Yarrish R, Marshak A, et al. Pharmacokinetic interaction between nevirapine and ethinyl estradiol/norethindrone when administered concurrently to HIV-infected women. J Acquir Immune Defic Syndr 2002; 29(5): 471-7.
55. World Health Organization. Medical eligibility criteria for contraceptive use--4th ed. Geneva 2009.
56. Dickinson BD, Altman RD, Nielsen NH, Sterling ML. Drug interactions between oral contraceptives and antibiotics. Obstet Gynecol 2001; 98(5 Pt 1): 853-60.
57. Anand A, Shiraishi RW, Bunnell RE, et al. Knowledge of HIV status, sexual risk behaviors and contraceptive need among people living with HIV in Kenya and Malawi. AIDS 2009; 23(12): 1565-73.
58. Elul B, Delvaux T, Munyana E, et al. Pregnancy desires, and contraceptive knowledge and use among prevention of mother-tochild transmission clients in Rwanda. AIDS 2009; 23: S19-26.
59. Bii SC, Otieno-Nyunya B, Siika A, Rotich JK. Family planning and safer sex practices among HIV infected women receiving prevention of mother-to-child transmission services at Kitale District Hospital. East Afr Med J 2008; 85(1): 46-50.
60. Keogh S, Urassa M, Kumogola Y, Mngara J, Zaba B. Reproductive behaviour and HIV status of antenatal clients in northern Tanzania: opportunities for family planning and preventing mother-to-child transmission integration. AIDS 2009; 23(1): S27-35.
61. Adair T. Unmet Need for Contraception among Hiv-Positive Women in Lesotho and Implications for Mother-to-Child Transmission. J Biosoc Sci 2009; 41(2): 269-78.
62. Nakayiwa S, Abang B, Packel L, et al. Desire for children and pregnancy risk behavior among HIV-infected men and women in Uganda. AIDS Behav 2006; 10(4 Suppl): S95-104.
63. Wanyenze R, Tumwesigye N, Kindyomunda R, et al. Uptake of family planning methods and unplanned pregnancies among HIVinfected individuals: a cross-sectional survey among clients at HIV clinics in Uganda. J Int AIDS Soc 2011; 14: 35.
64. Best K. Good counseling vital for clients with STDs. Network 1999 Winter;19(2): 23-5.
65. Ngubane N, Patel D, Newell ML, et al. Messages about dual contraception in areas of high HIV prevalence are not heeded. S Afr Med J 2008; 98(3): 209-12.
66. Nebie Y, Meda N, Leroy V, et al. Sexual and reproductive life of women informed of their HIV seropositivity: a prospective cohort study in Burkina Faso. J Acquir Immune Defic Syndr 2001; 28(4): 367-72.
67. Maharaj P. Obstacles to negotiating dual protection: perspectives of men and women. Afr J Reprod Health 2001; 5(3): 150-61.
68. Pulerwitz J, Michaelis A, Verma R, Weiss E. Addressing gender dynamics and engaging men in HIV programs: lessons learned from Horizons research. Public Health Rep 2010; 125(2): 282-92.
69. Bongaarts J, Bruce J. The Causes of Unmet Need for Contraception and the Social Content of Services. Stud Fam Plann 1995; 26(2): 57-75.
70. Upton RL. Perceptions of and attitudes towards male infertility in northern Botswana: some implications for family planning and AIDS prevention policies. Afr J Reprod Health 2002; 6(3): 103-11.
71. van der Straten A, Kang M, Posner S, Kamba M, Chipato T, Padian N. Predictors of diaphragm use as a potential sexually transmitted disease/HIV prevention method in Zimbabwe. Sex Transm Dis 2005; 32(1): 64-71.
72. Laher F, Todd C, Stibich M, et al. A Qualitative Assessment of Decisions Affecting Contraceptive Utilization and Fertility Intentions among HIV-Positive Women in Soweto, South Africa. AIDS Behav 2009; 13(0): 47-54.
73. Buck J, Kang M, van der Straten A, Khumalo-Sakutukwa G, Posner S, Padian N. Barrier method preferences and perceptions among Zimbabwean women and their partners. AIDS Behav 2005; 9(4): 415-22.
74. Welbourn A. Sex, Life and the Female Condom: Some Views of HIV Positive Women. Reprod Health Matters 2006; 14(28): 32-40.
75. Gutin SA, Mlobeli R, Moss M, Buga G, Morroni C. Survey of knowledge, attitudes and practices surrounding the intrauterine device in South Africa. Contraception 2010; 83(2): 145-50
76. Todd C, Stibich M, Laher F, et al. Influence of Culture on Contraceptive Utilization Among HIV-Positive Women in Brazil, Kenya, and South Africa. AIDS Behav 2011; 15(2): 454-68.
77. Mill JE, Anarfi JK. HIV risk environment for Ghanaian women: challenges to prevention. Soc Sci Med 2002; 54(3): 325-37.
78. Nanda K, Morrison CS, Kwok C, et al. Discontinuation of oral contraceptives and depot medroxyprogesterone acetate among women with and without HIV in Uganda, Zimbabwe and Thailand. Contraception. 2010 Sept; In Press, Corrected Proof.
79. Watts DH, Park J-G, Cohn SE, et al. Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093. Contraception 2008; 77(2): 84-90.
80. World Health Organization, UNFPA. Sexual and reproductive health of women living with HIV/AIDS: Guidelines on care, treatment and support for women living with HIV/AIDS and their children in resource-constrained settings. Geneva: World Health Organization 2006.
81. de Bruyn M. Safe abortion for HIV-positive women with unwanted pregnancy: a reproductive right. Reprod Health Matters 2003; 11(22): 152-61.
82. Sturt A, Dokubo E, Sint T. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Cochrane Database Syst Rev 2010; (3): CD008440.
83. World Health Organization. Rapid advice: use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants, November 2009. Accessed 17 Jan 2010: Available from: http://www.who.int/hiv/pub/mtct/advice/en/index.html.
84. Becquet R, Ekouevi D, Arrive E, et al. Universal antiretroviral therapy for pregnant and breast-feeding HIV-1-infected women: towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settings. Clin Infect Dis 2009; 49(12): 1936-45.
85. Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev 2007; (1): CD003510.
86. World Health Organization, International Confederation of Midwives, International Federation of Gynaecologists and Obstetricians. Making pregnancy safer: the critical role of the skilled attendant: a joint statement by WHO, ICM and FIGO. Geneva: World Health Organization 2004.
87. Chersich MF, Luchters SM, Yard E, Othigo JM, Kley N, Temmerman M. Morbidity in the first year postpartum among HIV-infected women in Kenya. Int J Gynaecol Obstet 2008; 100(1): 45-51.
88. Turan JM, Bukusi EA, Cohen CR, Sande J, Miller S. Effects of HIV/AIDS on maternity care providers in Kenya. J Obstet Gynecol Neonatal Nurs 2008; 37(5): 588-95.
89. Docquier F, Bhargava A. HIV pandemic, medical brain drain, and economic development in Sub-Saharan Africa. World Bank Econ Rev 2007; 22(2): 345-66.
90. Awases M, Gbary A, Nyoni J, Chatora R. Migration of health professionals in six countries: A synthesis report: World Health Organization, Regional office for Africa, Brazzaville, Republic of Congo 2003.
91. Bharat S, Mahendra VS. Meeting the sexual and reproductive health needs of people living with HIV: challenges for health care providers. Reprod Health Matters 2007; 15(29 Suppl): 93-112.
92. Wood K, Jewkes R. Blood blockages and scolding nurses: barriers to adolescent contraceptive use in South Africa. Reprod Health Matters 2006; 14(27): 109-18.
93. Harper CC, Chipato T, Nhemachena T, et al., editors. Provider HIV and pregnancy prevention practices in southern Africa: The female condom American Public Health Association Annual Meeting; 2010; Denver, CO.
94. Gaffikin L, Phiri A, McGrath J, Zinanga A, Blumenthal PD. Provider attitudes toward IUD provision in Zimbabwe: perception of HIV risk and training implications. Adv Contracept 1998; 14(1): 27-39.
95. Birungi H, Obare F, Mugisha JF, Evelia H, Nyombi J. Preventive service needs of young people perinatally infected with HIV in Uganda. AIDS Care 2009; 21(6): 725-31.
96. Cooper D, Bracken H, Myer L, et al. Reproductive intentions and choices among HIV-infected individuals in Cape Town, South Africa: Lessons for reproductive policy and service provision from a qualitative study. Population Council September 2005.
97. Mallet J, Kalambi V. Coerced and forced sterilization of HIVpositive women in Namibia. HIV AIDS Policy Law Rev 2008; 13(2-3): 77-8.
98. Callegari L, Harper C, van der Straten A, Kamba M, Chipato T, Padian N. Consistent condom use in married Zimbabwean women after a condom intervention. Sex Transm Dis 2008; 35(6): 624-30.
99. O'Leary A, Moore J, Khumalo-Sakutukwa G, et al. Association of negotiation strategies with consistent use of male condoms by women receiving an HIV prevention intervention in Zimbabwe. AIDS 2003; 17(11): 1705-7.
100. Napierala S, Kang M-S, Chipato T, Padian N, van der Straten A. Female condom uptake and acceptability in Zimbabwe. AIDS Educ Prev 2008; 20(2): 121-34.
101. Jones DL, Weiss SM, Bhat GJ, Bwalya V. Influencing sexual practices among HIV-positive Zambian women. AIDS Care 2006; 18(6): 629-34.
102. Engender Health. Reducing stigma and discrimination related to HIV and AIDS: Training for healthcare workers. New York2004. Accessed 11 nov 2010. Available from: http://www.engenderhea lth.org/hiv-tech-lib/pdf/manuals-training-programming/reducing_st igma_trainer_English.pdf.
103. Medley A, Kennedy C, O'Reilly K, Sweat M. Effectiveness of peer education interventions for HIV prevention in developing countries: a systematic review and meta-analysis. AIDS Educ Prev 2009; 21(3): 181-206.
104. Ringheim K, J G. Expanding Contraceptive Choice: Five Promising Innovations 2009. Accessed 17 Nov 2010. Available from: http://www.prb.org/pdf09/contraceptivechoice.pdf.
105. Karim Q, Karim S, Frohlich J, et al. on behalf of the CAPRISA 004 Trial Group. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science Express [serial on the Internet]. 2010; Online: http://www.sciencemag.org/cgi/rapidpdf/science.1193748.pdf: Available from: http://www.sciencemag.org/cgi/rapidpdf/science.1 193748.pdf.
106. Cohen M, Chen Y, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365(6): 493-505.
107. Celum. Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence. Curr Opin Infect Dis 2012; 25(1): 51-7.
108. World Health Organization. Strategic Considerations for Strengthening the Linkages between Family Planning and HIV/AIDS Policies, Programs, and Services. Geneva2009. Accessed 22 Jan 2010. Available from: http://www.hivandsrh.org/newsletter/Strategic_Considerations.pdf.
109. The IATT on Prevention of HIV Infection in Pregnant Women MatC. Guidance on global scale-up of the prevention of mother-tochild transmission of HIV: Towards universal access for women, infants and young children and eliminating HIV and AIDS among children. Geneva 2007. Accessed 22 Jan 2010. Available from: http://whqlibdoc.who.int/publications/2007/9789241596015_eng.p df.
110. Agadjanian V, Hayford S. PMTCT, HAART, and childbearing in Mozambique: an institutional perspective. AIDS Behav 2009; 13 Suppl 1: 103-12.
111. Wilcher R, Cates W. Reproductive choices for women with HIV. Bulletin of the World Health Organization [serial on the Internet]. 2009; 87: Accessed 11 Nov 2010. Available from: http://www. who.int/bulletin/volumes/87/11/08-059360/en/index.html.
112. Berer M. HIV/AIDS, sexual and reproductive health: intersections and implications for national programmes. Health Policy Plan 2004; 19 Suppl 1: i62-70.
113. Druce N, Nolan A. Seizing the big missed opportunity: linking HIV and maternity care services in Sub-Saharan Africa. Reprod Health Matters 2007; 15(30): 190-201.
114. Wilcher R, Petruney T, Reynolds HW, Cates W. From effectiveness to impact: contraception as an HIV prevention intervention. Sex Transm Infect 2008; 84 Suppl 2:ii54-60.
115. Strachan M, Kwateng-Addo A, Hardee K, Subramaniam S, Judice N, Agarwal K. An analysis of family planning content in HIV/AIDS, VCT, and PMTCT policies in 16 countries. Futures Group International [serial on the Internet] 2004; 9.
116. King R, Estey J, Allen S, et al. A family planning intervention to reduce vertical transmission of HIV in Rwanda. AIDS 1995; 9 Suppl 1: S45-51.
117. Chabikuli N, Awi D, Chukwujekwu O, et al. The use of routine monitoring and evaluation systems to assess a referral model of family planning and HIV service integration in Nigeria. AIDS 2009; 23 Suppl 1: S97-103.
118. Spaulding A, Brickley D, Kennedy C, et al. Linking family planning with HIV/AIDS interventions: a systematic review of the evidence. AIDS 2009; 23(1): S79-88.
119. Kennedy C, Spaulding A, Brickley D, et al. Linking sexual and reproductive health and HIV interventions: a systematic review. J Int AIDS Soc 2010; 13: 26.
120. Brickley D, Almers L, Kennedy C, et al. Sexual and reproductive health services for people living with HIV: a systematic review. AIDS Care 2011; 23(3): 303-14.